Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$4.04

-0.12 (-2.88%)

12:45
10/17/16
10/17
12:45
10/17/16
12:45

BioCryst has a conference call hosted by JPMorgan

JPMorgan Analysts Kasimov, Fye and Rama will host a conference with CEO Jon Stonehouse and CMO Bill Sheridan on October 17 at 1 pm.

  • 17

    Oct

  • 29

    Nov

BCRX BioCryst
$4.04

-0.12 (-2.88%)

08/12/16
PIPR
08/12/16
UPGRADE
Target $8
PIPR
Overweight
BioCryst upgraded to Overweight from Neutral at Piper Jaffray (pre-open)
Piper Jaffray analyst Charles Duncan upgraded before the market opened shares of BioCryst Pharmaceuticals to Overweight from Neutral. The analyst raised his price target for the shares to $8 from $5. Duncan thinks the company is "back on track and well-funded" to produce the first meaningful Phase II results as early as yearend after it dosed the first patient in its APeX-1 trial of '7353. The analyst continues to believe that an oral candidate for hereditary angioedema attack prevention can produce "significant clinical value." BioCryst is up 7% in late morning trading to $5.37.
08/04/16
JMPS
08/04/16
DOWNGRADE
JMPS
Market Perform
BioCryst downgraded to Market Perform from Outperform at JMP Securities
02/09/16
02/09/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Capital Senior Floating (ACSF) downgraded to Market Perform at Keefe Bruyette... American Science & Engineering (ASEI) downgraded to Hold from Buy at Benchmark... ArcelorMittal (MT) downgraded to Neutral from Overweight at JPMorgan... BioCryst (BCRX) downgraded to Hold from Buy at Jefferies... Brixmor (BRX) downgraded to Underperform from Outperform at RBC Capital... Diana Shipping (DSX) downgraded to Neutral from Buy at Clarksons Platou... Eagle Point Credit (ECC) downgraded to Neutral from Buy at Compass Point... Golden Ocean (GOGL) downgraded to Neutral from Buy at Clarksons Platou... Lukoil (LUKOY) downgraded to Hold from Buy at Deutsche Bank... Memorial Resource (MRD) downgraded to Neutral from Overweight at JPMorgan... Navios Maritime (NM) downgraded to Neutral from Buy at Clarksons Platou... Northstar Realty (NRF) downgraded to Market Perform from Outperform at Keefe Bruyette... Plains All American (PAA) downgraded to Neutral from Buy at BofA/Merrill... Plains GP Holdings (PAGP) downgraded to Neutral from Buy at BofA/Merrill... Qualys (QLYS) downgraded to Neutral from Buy at DA Davidson... Quidel (QDEL) downgraded to Hold from Buy at Canaccord... Randgold (GOLD) downgraded to Hold from Buy at Deutsche Bank... Scorpio Bulkers (SALT) downgraded to Neutral from Buy at Clarksons Platou... Tortoise Energy (TYG) downgraded to Hold from Buy at Stifel... Winnebago (WGO) downgraded to Neutral from Buy at Northcoast.
02/09/16
JEFF
02/09/16
DOWNGRADE
Target $2
JEFF
Hold
BioCryst downgraded to Hold from Buy at Jefferies
Jefferies analyst Brian Abrahams downgraded BioCryst to Hold citing higher risk and pushed out timelines following the Avoralstat Phase II failure. The analyst cut his price target for the shares to $2 from $14. JPMorgan this morning also downgraded BioCryst.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.